Cigna Group $CI Shares Sold by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC trimmed its position in Cigna Group (NYSE:CI) by 30.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,307 shares of the health services provider’s stock after selling 14,687 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Cigna Group were worth $9,442,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CI. Beacon Financial Strategies CORP acquired a new position in Cigna Group in the 4th quarter worth approximately $28,000. Lodestone Wealth Management LLC acquired a new stake in Cigna Group during the 4th quarter valued at approximately $32,000. Collier Financial acquired a new stake in shares of Cigna Group in the third quarter worth $34,000. Creative Financial Designs Inc. ADV increased its stake in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after acquiring an additional 81 shares during the period. Finally, Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after purchasing an additional 126 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of NYSE CI opened at $284.62 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company’s fifty day moving average price is $278.07 and its 200 day moving average price is $276.88. The company has a market capitalization of $75.29 billion, a PE ratio of 12.07, a price-to-earnings-growth ratio of 1.03 and a beta of 0.30.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter in the prior year, the firm posted $6.74 earnings per share. The company’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.45%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 205,904 shares of company stock valued at $60,277,068. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on CI shares. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Guggenheim boosted their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Mizuho set a $330.00 target price on Cigna Group in a research note on Friday, May 1st. Finally, Jefferies Financial Group dropped their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $339.50.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.